5AM Partners VI, LLC

CIK: 0001829051

Transaction Breakdown

Open Market Buys (P)3 (60.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CAMP

Camp4 Therapeutics Corp

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (5 total)

CAMP
Camp4 Therapeutics Corp
Aug 3, 2026
Purchase(P)
Pre-Funded Warrant (Right to Buy)
Indirect
3.2M shares at avg. $1.53-
CAMP
Camp4 Therapeutics Corp
Sep 11, 2025
Purchase(P)
Indirect
2.9M shares at avg. $1.53$4.5M
CAMP
Camp4 Therapeutics Corp
Oct 15, 2024
Conversion(C)
Indirect
1.7M shares-
CAMP
Camp4 Therapeutics Corp
Oct 15, 2024
Conversion(C)
Indirect
302.8K shares-
CAMP
Camp4 Therapeutics Corp
Oct 15, 2024
Purchase(P)
Indirect
909.1K shares at avg. $11.00$10.0M

		Type	Shares	Price		Ownership
Aug 3, 2026	CAMP Camp4 Therapeutics Corp	Purchase(P) Pre-Funded Warrant (Right to Buy)	3,179,558	$1.53	-	Indirect
Sep 11, 2025	CAMP Camp4 Therapeutics Corp	Purchase(P)	2,941,176	$1.53	$4,499,999	Indirect
Oct 15, 2024	CAMP Camp4 Therapeutics Corp	Conversion(C)	1,716,055	-	$0	Indirect
Oct 15, 2024	CAMP Camp4 Therapeutics Corp	Conversion(C)	302,770	-	$0	Indirect
Oct 15, 2024	CAMP Camp4 Therapeutics Corp	Purchase(P)	909,090	$11.00	$9,999,990	Indirect

1-5 of 5 transactions

About 5AM Partners VI, LLC

5AM Partners VI, LLC (SEC CIK 0001829051) files insider reports with the SEC as 10% Owner of Camp4 Therapeutics Corp (CAMP).

Signal8 holds 4 ownership filings by 5AM Partners VI, LLC (1 Form 3, 3 Form 4), filed between Oct 10, 2024 and Aug 5, 2026. Those filings report 5 transactions, from Oct 15, 2024 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on 5AM Partners VI, LLC's filings is in SAN FRANCISCO, CA.

Recent filings by 5AM Partners VI, LLC

Aug 3, 2026: Open-market purchase of CAMP derivative securities (Form 4, code P).
Sep 11, 2025: Open-market purchase of CAMP shares (Form 4, code P).
Oct 15, 2024: Conversions of CAMP shares (2 lines, Form 4, code C).
Oct 15, 2024: Open-market purchase of CAMP shares (Form 4, code P).

Other insiders filing for Camp4 Therapeutics Corp (CAMP)

Gold Kelly, Chief Financial Officer
Schwab Andrew J., Director
Tardiff Daniel, Chief Scientific Officer
Young Richard A, Director
Maricich Yuri, Chief Medical Officer
Mandel-Brehm Josh, Chief Executive Officer

How to read Form 4 transaction codes